ASC Therapeutics Receives Key Regulatory Designations in U.S. and Europe to Advance its Second-Generation Gene Therapy for Hemophilia A

* Recent U.S. FDA's Fast-Track Designation * Recent European Medicines Agency's Positive Opinion on Orphan Medical Product Designation * Previous FDA's IND Clearance and FDA's Orphan Drug Designation MILPITAS, Calif. [...]